Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.10.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Investment in real estate:    
Land $ 56,839 $ 42,701
Building 493,503 384,338
Site improvements 6,714 4,808
Tenant improvements 14,328 8,010
Acquired lease intangible assets 41,653 31,650
Real Estate Investment Property, at Cost, Total 613,037 471,507
Less: accumulated depreciation and amortization (26,839) (13,594)
Investment in real estate, net 586,198 457,913
Cash and cash equivalents 3,005 5,109
Restricted cash 817 2,005
Tenant receivables 1,744 704
Escrow deposits 2,628 1,638
Deferred assets 8,590 3,993
Other assets 1,109 459
Total assets 604,091 471,821
Liabilities:    
Revolving credit facility, net of unamortized discount of $4,127 and $2,750 at September 30, 2018 and December 31, 2017, respectively 293,273 162,150
Notes payable, net of unamortized discount of $832 and $930 at September 30, 2018 and December 31, 2017, respectively 38,643 38,545
Accounts payable and accrued expenses 4,420 2,020
Dividends payable 6,109 5,638
Security deposits and other 3,928 2,128
Due to related parties, net 1,028 1,036
Acquired lease intangible liability, net 2,034 1,291
Total liabilities 349,435 212,808
Stockholders' equity:    
Preferred stock, $0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at September 30, 2018 and December 31, 2017 (liquidation preference of $77,625 at September 30, 2018 and December 31, 2017) 74,959 74,959
Common stock, $0.001 par value, 500,000 shares authorized; 22,003 shares and 21,631 shares issued and outstanding at September 30, 2018 and December 31, 2017 22 22
Additional paid-in capital 208,938 205,788
Accumulated deficit (46,855) (34,434)
Accumulated other comprehensive loss (109) 0
Total Global Medical REIT Inc. stockholders' equity 236,955 246,335
Noncontrolling interest 17,701 12,678
Total stockholders' equity 254,656 259,013
Total liabilities and stockholders' equity $ 604,091 $ 471,821